| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.6M | +5.2% |
| Cost of Revenue | $6.8M | -2.7% |
| Gross Profit | $6.8M | +14.6% |
| R&D Expense | $17.5M | -22.4% |
| SG&A Expense | $16.3M | -7.1% |
| Operating Income | -$37.1M | +14.2% |
| Pre-tax Income | -$35.6M | +12.6% |
| Income Tax | $0 | — |
| Net Income | -$35.6M | +12.6% |
| EPS (Basic) | -$0.43 | +23.2% |
| EPS (Diluted) | -$0.43 | +23.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.1M | -6.8% |
| Accounts Receivable | $5.3M | -11.8% |
| Inventory | $7.1M | +21.6% |
| Current Assets | $50.9M | -5.2% |
| Total Assets | $55.3M | -6.2% |
| Current Liabilities | $11.7M | +34.4% |
| Total Liabilities | $14.3M | +44.6% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.9M | +27.9% |
| Capital Expenditures | $1.2M | +209.4% |
| Investing Cash Flow | -$1.2M | -209.4% |
| Financing Cash Flow | $27.5M | +2598.9% |
| Free Cash Flow | -$29.1M | +25.6% |
| $41.0M |
| -16.4% |